Literature DB >> 29287822

SRS-22R Minimum Clinically Important Difference and Substantial Clinical Benefit After Adult Lumbar Scoliosis Surgery.

Leah Y Carreon1, Michael P Kelly2, Charles H Crawford3, Christine R Baldus2, Steven D Glassman3, Christopher I Shaffrey4, Keith H Bridwell2.   

Abstract

STUDY
DESIGN: Longitudinal cohort.
OBJECTIVES: To determine if the minimum clinically important difference (MCID) and substantial clinical benefit (SCB) thresholds for the Scoliosis Research Society-22R (SRS22R) domains in patients with degenerative lumbar scoliosis are similar to those in patients with adult spinal deformity (ASD) with fusions extending into the thoracic spine. SUMMARY OF BACKGROUND DATA: The MCID and SCB thresholds for the SRS22R domains in patients with ASD and adolescent idiopathic scoliosis have been reported.
METHODS: Patients enrolled in the NIH-sponsored Adult Symptomatic Lumbar Scoliosis (ASLS) trial who underwent surgery and completed the SRS22R preoperative and the SRS30 one-year postoperative were identified. One-year postoperative answers to the last eight questions of the SRS30 were used as anchors to determine the MCID and SCB for the Pain, Appearance, and Activity domains, and the Subscore and Total score using receiver operating characteristic (ROC) curve analysis.
RESULTS: The sample population consisted of 147 patients. A total of 132 (89%) were females with a mean age of 59.4 years. There was a statistically significant improvement in all SRS22R scores from preoperative to one-year postoperative. There was also a statistically significant difference in domain scores among the different responses to the anchors. According to the ROC analysis, MCID was 1.17 for Appearance, 0.40 for Activity, 0.60 for Pain, 0.53 for Subscore, and 0.77 for Total; and SCB was 1.67 for Appearance, 0.60 for Activity, 0.62 for Subscore, and 1.11 for Total score. These are similar to previous reports of MCID and SCB thresholds for ASD patients who underwent fusion to the thoracic spine.
CONCLUSION: The MCID and SCB thresholds for the SRS22R domains in patients with adult symptomatic lumbar scoliosis are very similar to the threshold values previously reported for adult deformity patients. LEVEL OF EVIDENCE: Level II.
Copyright © 2017 Scoliosis Research Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult lumbar spine deformity; Minimum clinically important difference; SRS-22R

Mesh:

Year:  2018        PMID: 29287822      PMCID: PMC5751965          DOI: 10.1016/j.jspd.2017.05.006

Source DB:  PubMed          Journal:  Spine Deform        ISSN: 2212-134X


  12 in total

1.  The validity of the SRS-22 instrument in an adult spinal deformity population compared with the Oswestry and SF-12: a study of response distribution, concurrent validity, internal consistency, and reliability.

Authors:  Keith H Bridwell; William Cats-Baril; John Harrast; Sigurd Berven; Steven Glassman; Jean-Pierre Farcy; William C Horton; Lawrence G Lenke; Christine Baldus; Terri Radake
Journal:  Spine (Phila Pa 1976)       Date:  2005-02-15       Impact factor: 3.468

2.  The Substantial Clinical Benefit Threshold for SRS-22R Domains After Surgical Treatment of Adult Spinal Deformity.

Authors:  Charles H Crawford; Steven D Glassman; Keith H Bridwell; Leah Y Carreon
Journal:  Spine Deform       Date:  2016-08-21

3.  Measurement of health status. Ascertaining the minimal clinically important difference.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1989-12

4.  Refinement of the SRS-22 Health-Related Quality of Life questionnaire Function domain.

Authors:  Marc A Asher; Sue Min Lai; R Chris Glattes; Douglas C Burton; Ahmet Alanay; Juan Bago
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

5.  The clinical importance of changes in outcome scores after treatment for chronic low back pain.

Authors:  O Hägg; P Fritzell; A Nordwall
Journal:  Eur Spine J       Date:  2002-10-24       Impact factor: 3.134

6.  Is the SRS-22 instrument responsive to change in adult scoliosis patients having primary spinal deformity surgery?

Authors:  Keith H Bridwell; Sigurd Berven; Steven Glassman; Christopher Hamill; William C Horton; Lawrence G Lenke; Frank Schwab; Christine Baldus; Michael Shainline
Journal:  Spine (Phila Pa 1976)       Date:  2007-09-15       Impact factor: 3.468

7.  Defining substantial clinical benefit following lumbar spine arthrodesis.

Authors:  Steven D Glassman; Anne G Copay; Sigurd H Berven; David W Polly; Brian R Subach; Leah Y Carreon
Journal:  J Bone Joint Surg Am       Date:  2008-09       Impact factor: 5.284

8.  Studies in the modified Scoliosis Research Society Outcomes Instrument in adults: validation, reliability, and discriminatory capacity.

Authors:  Sigurd Berven; Vedat Deviren; Sibel Demir-Deviren; Serena S Hu; David S Bradford
Journal:  Spine (Phila Pa 1976)       Date:  2003-09-15       Impact factor: 3.468

9.  Scoliosis research society-22 patient questionnaire: responsiveness to change associated with surgical treatment.

Authors:  Marc Asher; Sue Min Lai; Doug Burton; Barbara Manna
Journal:  Spine (Phila Pa 1976)       Date:  2003-01-01       Impact factor: 3.468

10.  Discrimination validity of the scoliosis research society-22 patient questionnaire: relationship to idiopathic scoliosis curve pattern and curve size.

Authors:  Marc Asher; Sue Min Lai; Doug Burton; Barbara Manna
Journal:  Spine (Phila Pa 1976)       Date:  2003-01-01       Impact factor: 3.468

View more
  2 in total

Review 1.  State-of-the-art: outcome assessment in adult spinal deformity.

Authors:  Jeffrey L Gum; Leah Y Carreon; Steven D Glassman
Journal:  Spine Deform       Date:  2020-10-09

2.  Adult Congenital Spine Deformity: Clinical Features and Motivations for Surgical Treatment.

Authors:  Javier Pizones; Lucía Moreno-Manzanaro; Alba Vila-Casademunt; Nicomedes Fernández-Baíllo; José Sánchez-Márquez; Gloria Talavera; Ibrahim Obeid; Ahmet Alanay; Frank Kleinstück; Ferran Pellisé; Francisco Javier Sánchez Perez-Grueso
Journal:  Int J Spine Surg       Date:  2021-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.